![](https://www.Immune-System-Research.com/"wp-content/uploads"/2022/01/Licogliflozin-is-a-dual-SGLT1-and-SGLT2-Inhibitor-2022-01-18.jpg)
In general, obesity more greatly contributes to the global burden of disease (also associated with co-morbidities) in recent years .…
![](https://www.Immune-System-Research.com/"wp-content/uploads"/2021/03/PF-05221304-is-an-Orally-Active-Liver-Directed-and-Dual-ACC1-and-ACC2-Inhibitor-2021-03-17.jpg)
The character of nonalcoholic fatty liver disease (NAFLD) is the accumulation of fat (in excess of 5%) within the hepatocytes.…